S7 - Aging and Dementia: Clinical and Translational Studies in Neurodegenerative Diseases

Event Time: Sunday April 23, 2017 3:30 pm to 5:30 pm
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s):
Description: A group of abstracts covering a similar topic presented in an oral format. Presentations are eight minutes in length with four minutes of question and answer. Each session concludes with 25 minutes of a discussant bringing additional context to one or more of the abstracts.
Completion Message:
CME Credits: 2
Core Competencies:

Abstract Presenters

Start Time Pub. Title Presenter
3:54 PM 003 Titration dosing of aducanumab: Results of a 12-month interim analysis from a randomized, double-blind, placebo-controlled Phase 1b study (PRIME) in patients with prodromal or mild Alzheimer's Disease Vissia Viglietta
Disclosure:
Dr. Viglietta has received personal compensation for activities with Biogen as an employee. Dr. Viglietta holds stock and/or stock options in Biogen.

4:06 PM 004 An Investigation on Repetitive Head Impact Exposure and Plasma Total Tau Concentrations in Former National Football League Players Michael Alosco
Disclosure:
Dr. Alosco has nothing to disclose.

4:18 PM 005 Crenezumab′s Preferential Binding Of Oligomeric Amyloid-Beta Species Underlies Its Unique Mechanism Of Action Jasvinder Atwal
Disclosure:
Dr. Atwal has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Genentech.

4:30 PM 006 Comparison of detergent-insoluble proteome changes in autosomal dominant Alzheimer′s disease brain to late onset AD and transgenic rodents Chad Hales, MD, PhD
Disclosure:
Dr. Hales has nothing to disclose.

4:42 PM 007 Sporadic FTLD TDP type C is a distinct clinicopathological entity from FTLD types A/B G Michael Baer
Disclosure:
Dr. Baer has nothing to disclose.

4:54 PM 008 Mortality and risk of dementia in normal pressure hydrocephalus: 25-year follow-up of a population-based cohort Daniel Jaraj
Disclosure:
Dr. Jaraj has nothing to disclose.

Register Now

Related Courses